SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-314902
Filing Date
2020-12-10
Accepted
2020-12-10 16:23:01
Documents
14
Period of Report
2020-12-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d13482d8k.htm   iXBRL 8-K 25654
2 EX-99.1 d13482dex991.htm EX-99.1 72363
6 GRAPHIC g13482dsp5.jpg GRAPHIC 6622
  Complete submission text file 0001193125-20-314902.txt   243544

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20201210.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20201210_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20201210_pre.xml EX-101.PRE 11876
7 EXTRACTED XBRL INSTANCE DOCUMENT d13482d8k_htm.xml XML 3517
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 201380877
SIC: 8071 Services-Medical Laboratories